• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT LINK 2.4; BLOOD GLUCOSE METER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT LINK 2.4; BLOOD GLUCOSE METER Back to Search Results
Model Number 6260
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code Hyperglycemia (1905)
Date of Event 08/25/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The patient/family was the initial reporter, so personal information was not entered.No information was captured as the customer's age and weight were not provided.
 
Event or Problem Description
The customer reported that she obtained inaccurate readings with the contour next link 2.4 meter.No specific reading from the event was provided.The customer stated that she was experiencing symptoms of hyperglycemia and took insulin.The customer felt sick after administering insulin and went to the hospital.The customer declined to provide any further event details.The customer was advised to return the device for evaluation.Replacement meter kit and test strips were sent to the customer.Since the strip information was not provided, this report will be submitted under the meter information.
 
Additional Manufacturer Narrative
The customer did not return the suspected device for evaluation.Therefore, the device history record was reviewed for the suspected contour next link 2.4 meter and no manufacturing anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT LINK 2.4
Common Device Name
BLOOD GLUCOSE METER
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION #: 3004167884)
110 oaza-inoshiri-aza
-nishiueno, wakimachi
mima tokusima, 779-3 603
JA   779-3603
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key12468406
Report Number1810909-2021-00343
Device Sequence Number17088685
Product Code NBW
UDI-Device Identifier00301936260019
UDI-Public00301936260019
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P150001
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 08/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model Number6260
Device Catalogue Number6260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/25/2021
Supplement Date Received by Manufacturer06/24/2022
Initial Report FDA Received Date09/14/2021
Supplement Report FDA Received Date06/27/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/16/2017
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient SexFemale
-
-